Ignite Creation Date:
2024-07-17 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06479863
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-05-24
Brief Title:
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Sponsor:
Austin Neuromuscular Center
Organization:
Austin Neuromuscular Center
Organization Data
Organization:
Austin Neuromuscular Center
Class:
OTHER
Study ID:
R3918-OT-2383
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Austin Neuromuscular Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Regeneron Pharmaceuticals | INDUSTRY |